These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14710994)

  • 21. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Moulding T
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
    [No Abstract]   [Full Text] [Related]  

  • 22. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi drug resistant tuberculosis.
    Githui WA
    East Afr Med J; 2006 Nov; 83(11):585-7. PubMed ID: 17455446
    [No Abstract]   [Full Text] [Related]  

  • 24. Surrogate markers to assess new therapies for drug-resistant tuberculosis.
    Wallis RS
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):163-8. PubMed ID: 17402829
    [No Abstract]   [Full Text] [Related]  

  • 25. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standard chemotherapy for multidrug-resistant tuberculosis based on establishment of guidelines].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):483-4. PubMed ID: 20979794
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid resistant TB and non-compliance.
    van Altena R; van Soolingen D; van der Werf TS
    Thorax; 2004 Dec; 59(12):1098; author reply 1098-9. PubMed ID: 15563712
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 30. Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment.
    Tabarsi P; Baghaei P; Mirsaeidi M; Amiri M; Mansouri D; Novin A; Zendedel SM; Masjedi MR
    Infection; 2007 Dec; 35(6):477-8. PubMed ID: 17906837
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluoroquinolones and tuberculosis.
    Yew WW; Chau CH
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):1050-2. PubMed ID: 9869128
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficiency of partial pneumonectomies in patients with multidrug-resistant tuberculosis].
    Giller DB; Shaĭkhaev AIa; Vasil'eva IA; Ziuzia IuR; Enilenis II; Asanov BM; Isaeva TKh; Volynkin SV; Papkov AV; Sadovnikova SS
    Probl Tuberk Bolezn Legk; 2008; (5):6-10. PubMed ID: 18710039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extremely resistant tuberculosis in Africa. The Danish Society for Tropical Medicine and International Health].
    Ravn P; Vestergaard LS; David KP;
    Ugeskr Laeger; 2007 Mar; 169(12):1135. PubMed ID: 17394846
    [No Abstract]   [Full Text] [Related]  

  • 35. Rebuttal: Evidence and uncertainties.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):651-3. PubMed ID: 12150474
    [No Abstract]   [Full Text] [Related]  

  • 36. Rebuttal, evidence and debate.
    Harper I
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):100. PubMed ID: 12701844
    [No Abstract]   [Full Text] [Related]  

  • 37. The future may not be so dark.
    Espinal MA; Gupta R; Raviglione MC
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):787-8. PubMed ID: 11573888
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era?
    Ollé-Goig JE
    Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741
    [No Abstract]   [Full Text] [Related]  

  • 39. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-resolving choroidal tubercles may indicate multidrug resistant (MDR) tuberculosis.
    Mehta S
    J Assoc Physicians India; 2004 Jan; 52():81. PubMed ID: 15633731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.